XENETIX 300 (300 mg d'Iode/mL), solution injectable — 1 flacon(s) en verre de 150 ml avec dispositif(s) d'administration pour injecteur Medrad Stellant (1 seringue + 1 prolongateur + 1 cathéter sécurisé 20G)
Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France
-
CIP13
3400930107447 -
CIP7
3010744 -
CIS
68324489
What the source publishes
- Holder
- GUERBET
- Active ingredients
- IODE, IOBITRIDOL
- Form
- solution injectable
- Package
- 1 flacon(s) en verre de 150 ml avec dispositif(s) d'administration pour injecteur Medrad Stellant (1 seringue + 1 prolongateur + 1 cathéter sécurisé 20G)
- Routes
- intra-utérine, intraarticulaire, intraartérielle, intracholangiopancréatique, intraveineuse
- Administrative status
- authorised
- Supply regime
- liste I
- Marketing status
- Déclaration d'arrêt de commercialisation
- Authorised on
- 1994-08-24
- Prescription
- Prescription or restricted
Names this record is found by
- XENETIX 300 (300 mg d'Iode/mL), solution injectable — 1 flacon(s) en verre de 150 ml avec dispositif(s) d'administration pour injecteur Medrad Stellant (1 seringue + 1 prolongateur + 1 cathéter sécurisé 20G)
- XENETIX 300 (300 mg d'Iode/mL), solution injectable
- IODE
- IOBITRIDOL
Complete source data
{
"cis": "68324489",
"cip7": "3010744",
"form": "solution injectable",
"name": "XENETIX 300 (300 mg d'Iode/mL), solution injectable — 1 flacon(s) en verre de 150 ml avec dispositif(s) d'administration pour injecteur Medrad Stellant (1 seringue + 1 prolongateur + 1 cathéter sécurisé 20G)",
"cip13": "3400930107447",
"holder": "GUERBET",
"routes": [
"intra-utérine",
"intraarticulaire",
"intraartérielle",
"intracholangiopancréatique",
"intraveineuse"
],
"holders": [
"GUERBET"
],
"currency": "EUR",
"marketed": false,
"bdmStatus": null,
"useDomain": "unknown",
"publicPrice": null,
"authorisedOn": "1994-08-24",
"compositions": [
{
"name": "IODE",
"nature": "FT",
"strength": "30,0000 g",
"linkageNumber": "1",
"substanceCode": "00549",
"dosageReference": "100 ml de solution",
"pharmaceuticalElement": "solution"
},
{
"name": "IOBITRIDOL",
"nature": "SA",
"strength": "65,8100 g",
"linkageNumber": "1",
"substanceCode": "35195",
"dosageReference": "100 ml de solution",
"pharmaceuticalElement": "solution"
}
],
"sourceStatus": "Présentation active",
"supplyRegime": "liste I",
"dispensingFee": null,
"medicinePrice": null,
"regionalRules": "not-collected",
"targetSpecies": [],
"specialityName": "XENETIX 300 (300 mg d'Iode/mL), solution injectable",
"marketingStatus": "Déclaration d'arrêt de commercialisation",
"publicationDates": {
"CIS_bdpm": "2026-01-08",
"CIS_CIP_bdpm": "2026-11-19",
"CIS_CPD_bdpm": "2026-01-08",
"CIS_COMPO_bdpm": "2026-01-08"
},
"specialityListed": true,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "fr.ansm.bdpm"
},
"collectiveApproval": "non",
"packageDescription": "1 flacon(s) en verre de 150 ml avec dispositif(s) d'administration pour injecteur Medrad Stellant (1 seringue + 1 prolongateur + 1 cathéter sécurisé 20G)",
"patientEligibility": "not-assessed",
"reimbursementRates": [],
"marketingDeclaredOn": "2025-05-31",
"targetSpeciesStatus": "not-reported",
"additionalMonitoring": false,
"administrativeStatus": "authorised",
"prescriptionCategory": "prescription-or-restricted",
"activeIngredientNames": [
"IODE",
"IOBITRIDOL"
],
"authorisationProcedure": "Procédure nationale",
"prescriptionConditions": [
"liste I"
],
"reimbursementIndications": null,
"authorisationSourceStatus": "Autorisation active",
"europeanAuthorisationNumber": null,
"presentationAdministrativeStatus": "authorised"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=fr" \
--data-urlencode "sourceId=fr.ansm.bdpm" \
--data-urlencode "id=fr:ansm:packages:3400930107447"